894 related articles for article (PubMed ID: 19584287)
21. Vanillin suppresses in vitro invasion and in vivo metastasis of mouse breast cancer cells.
Lirdprapamongkol K; Sakurai H; Kawasaki N; Choo MK; Saitoh Y; Aozuka Y; Singhirunnusorn P; Ruchirawat S; Svasti J; Saiki I
Eur J Pharm Sci; 2005 May; 25(1):57-65. PubMed ID: 15854801
[TBL] [Abstract][Full Text] [Related]
22. Involvement of matrix metalloproteinase-7 in invasion-metastasis through induction of cell dissociation in pancreatic cancer.
Tan X; Egami H; Ishikawa S; Sugita H; Kamohara H; Nakagawa M; Nozawa F; Abe M; Ogawa M
Int J Oncol; 2005 May; 26(5):1283-9. PubMed ID: 15809719
[TBL] [Abstract][Full Text] [Related]
23. Blocking tumor growth, invasion, and metastasis by maspin in a syngeneic breast cancer model.
Shi HY; Zhang W; Liang R; Abraham S; Kittrell FS; Medina D; Zhang M
Cancer Res; 2001 Sep; 61(18):6945-51. PubMed ID: 11559574
[TBL] [Abstract][Full Text] [Related]
24. Microenvironment of the murine mammary carcinoma 4T1: endogenous IFN-gamma affects tumor phenotype, growth, and metastasis.
duPre' SA; Redelman D; Hunter KW
Exp Mol Pathol; 2008 Dec; 85(3):174-88. PubMed ID: 18929358
[TBL] [Abstract][Full Text] [Related]
25. Protease nexin 1 and its receptor LRP modulate SHH signalling during cerebellar development.
Vaillant C; Michos O; Orolicki S; Brellier F; Taieb S; Moreno E; Té H; Zeller R; Monard D
Development; 2007 May; 134(9):1745-54. PubMed ID: 17409116
[TBL] [Abstract][Full Text] [Related]
26. Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model.
Merchan JR; Tang J; Hu G; Lin Y; Mutter W; Tong C; Karumanchi SA; Russell SJ; Sukhatme VP
J Natl Cancer Inst; 2006 Jun; 98(11):756-64. PubMed ID: 16757700
[TBL] [Abstract][Full Text] [Related]
27. Somatic mutation of p53 leads to estrogen receptor alpha-positive and -negative mouse mammary tumors with high frequency of metastasis.
Lin SC; Lee KF; Nikitin AY; Hilsenbeck SG; Cardiff RD; Li A; Kang KW; Frank SA; Lee WH; Lee EY
Cancer Res; 2004 May; 64(10):3525-32. PubMed ID: 15150107
[TBL] [Abstract][Full Text] [Related]
28. Fibronectin is distinctly downregulated in murine mammary adenocarcinoma cells with high metastatic potential.
Urtreger AJ; Werbajh SE; Verrecchia F; Mauviel A; Puricelli LI; Kornblihtt AR; Bal de Kier Joffé ED
Oncol Rep; 2006 Dec; 16(6):1403-10. PubMed ID: 17089068
[TBL] [Abstract][Full Text] [Related]
29. Low-density lipoprotein receptor-related protein contributes to the antiangiogenic activity of thrombospondin-2 in a murine glioma model.
Fears CY; Grammer JR; Stewart JE; Annis DS; Mosher DF; Bornstein P; Gladson CL
Cancer Res; 2005 Oct; 65(20):9338-46. PubMed ID: 16230396
[TBL] [Abstract][Full Text] [Related]
30. Sodium hydrogen exchanger and phospholipase D are required for alpha1-adrenergic receptor stimulation of metalloproteinase-9 and cellular invasion in CCL39 fibroblasts.
Taves J; Rastedt D; Canine J; Mork D; Wallert MA; Provost JJ
Arch Biochem Biophys; 2008 Sep; 477(1):60-6. PubMed ID: 18539131
[TBL] [Abstract][Full Text] [Related]
31. Galectin-1-mediated tumor invasion and metastasis, up-regulated matrix metalloproteinase expression, and reorganized actin cytoskeletons.
Wu MH; Hong TM; Cheng HW; Pan SH; Liang YR; Hong HC; Chiang WF; Wong TY; Shieh DB; Shiau AL; Jin YT; Chen YL
Mol Cancer Res; 2009 Mar; 7(3):311-8. PubMed ID: 19276182
[TBL] [Abstract][Full Text] [Related]
32. Suppression of NF-kappaB activity by NDRG2 expression attenuates the invasive potential of highly malignant tumor cells.
Kim A; Kim MJ; Yang Y; Kim JW; Yeom YI; Lim JS
Carcinogenesis; 2009 Jun; 30(6):927-36. PubMed ID: 19336468
[TBL] [Abstract][Full Text] [Related]
33. MEKK1 controls matrix degradation and tumor cell dissemination during metastasis of polyoma middle-T driven mammary cancer.
Cuevas BD; Winter-Vann AM; Johnson NL; Johnson GL
Oncogene; 2006 Aug; 25(36):4998-5010. PubMed ID: 16568086
[TBL] [Abstract][Full Text] [Related]
34. Cathepsin G enhances mammary tumor-induced osteolysis by generating soluble receptor activator of nuclear factor-kappaB ligand.
Wilson TJ; Nannuru KC; Futakuchi M; Sadanandam A; Singh RK
Cancer Res; 2008 Jul; 68(14):5803-11. PubMed ID: 18632634
[TBL] [Abstract][Full Text] [Related]
35. Soybean saponin inhibits tumor cell metastasis by modulating expressions of MMP-2, MMP-9 and TIMP- 2.
Kang JH; Han IH; Sung MK; Yoo H; Kim YG; Kim JS; Kawada T; Yu R
Cancer Lett; 2008 Mar; 261(1):84-92. PubMed ID: 18086515
[TBL] [Abstract][Full Text] [Related]
36. Genomic analysis of a spontaneous model of breast cancer metastasis to bone reveals a role for the extracellular matrix.
Eckhardt BL; Parker BS; van Laar RK; Restall CM; Natoli AL; Tavaria MD; Stanley KL; Sloan EK; Moseley JM; Anderson RL
Mol Cancer Res; 2005 Jan; 3(1):1-13. PubMed ID: 15671244
[TBL] [Abstract][Full Text] [Related]
37. Bcl-2-mediated cell survival promotes metastasis of EpH4 betaMEKDD mammary epithelial cells.
Pinkas J; Martin SS; Leder P
Mol Cancer Res; 2004 Oct; 2(10):551-6. PubMed ID: 15498929
[TBL] [Abstract][Full Text] [Related]
38. Osteopontin increases migration and MMP-9 up-regulation via alphavbeta3 integrin, FAK, ERK, and NF-kappaB-dependent pathway in human chondrosarcoma cells.
Chen YJ; Wei YY; Chen HT; Fong YC; Hsu CJ; Tsai CH; Hsu HC; Liu SH; Tang CH
J Cell Physiol; 2009 Oct; 221(1):98-108. PubMed ID: 19475568
[TBL] [Abstract][Full Text] [Related]
39. Global gene expression profiling unveils S100A8/A9 as candidate markers in H-ras-mediated human breast epithelial cell invasion.
Moon A; Yong HY; Song JI; Cukovic D; Salagrama S; Kaplan D; Putt D; Kim H; Dombkowski A; Kim HR
Mol Cancer Res; 2008 Oct; 6(10):1544-53. PubMed ID: 18922970
[TBL] [Abstract][Full Text] [Related]
40. Galectin-9 as a prognostic factor with antimetastatic potential in breast cancer.
Irie A; Yamauchi A; Kontani K; Kihara M; Liu D; Shirato Y; Seki M; Nishi N; Nakamura T; Yokomise H; Hirashima M
Clin Cancer Res; 2005 Apr; 11(8):2962-8. PubMed ID: 15837748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
